Global Herpes Marker Testing Market Research Report 2022

Market Analysis and Insights: Global Herpes Marker Testing Market
Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.
The global Herpes Marker Testing market size is projected to reach US$ 93 million by 2028, from US$ 74 million in 2021, at a CAGR of 3.3% during 2022-2028.
Fully considering the economic change by this health crisis, HSV-1 accounting for % of the Herpes Marker Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Research segment is altered to an % CAGR throughout this forecast period.
China Herpes Marker Testing market size is valued at US$ million in 2021, while the North America and Europe Herpes Marker Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Herpes Marker Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Marker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Marker Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Marker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Marker Testing market.
Global Herpes Marker Testing Scope and Market Size
Herpes Marker Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Herpes Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
HSV-1
HSV-2
HSV-1/ HSV-2
Segment by Application
Research
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics